LID, and their relationship are not known. In striatal neurons, D 1 R activates adenylyl-cyclase through G␣ olf , a protein upregulated after lesion of DA neurons in rats and in patients. We report here that increased G␣ olf levels in hemiparkinsonian mice are correlated with LID after chronic L-DOPA treatment. To determine the role of this upregulation, we performed unilateral lesion in mice lacking one allele of the Gnal gene coding for G␣ olf (Gnal ϩ/Ϫ ). Despite an increase in the lesioned striatum, G␣ olf levels remained below those of unlesioned wild-type mice. In Gnal ϩ/Ϫ mice, the lesion-induced L-DOPA stimulation of cAMP/PKA-mediated phosphorylation of GluA1 Ser845 and DARPP-32 (32 kDa DA-and cAMP-regulated phosphoprotein) Thr34 was dramatically reduced, whereas ERK activation was preserved. LID occurrence was similar in Gnal ϩ/ϩ and Gnal ϩ/Ϫ mice after a 10-d L-DOPA (20 mg/kg) treatment. Thus, in lesioned animals, G␣ olf upregulation is critical for the activation by L-DOPA of D 1 R-stimulated cAMP/PKA but not ERK signaling. Although the cAMP/PKA pathway appears to be required for LID development, our results indicate that its activation is unlikely to be the main source of LID. In contrast, the persistence of L-DOPAinduced ERK activation in Gnal ϩ/Ϫ mice supports its causal role in LID development.